Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.705
+0.005 (0.29%)
At close: Apr 2, 2026, 4:00 PM EDT
1.700
-0.005 (-0.29%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $95.92 million as of April 2, 2026. Its market cap has decreased by -16.44% in one year.
Market Cap
95.92M
Enterprise Value
-66.33M
1-Year Change
-16.44%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $95.92M, a decrease of -97.07%. That is a compound annual growth rate of -48.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 95.92M | -6.82% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 103.33M |
| Aldeyra Therapeutics | 99.90M |
| Turn Therapeutics | 98.64M |
| Spruce Biosciences | 96.72M |
| Coya Therapeutics | 94.06M |
| Verrica Pharmaceuticals | 93.97M |
| Aardvark Therapeutics | 93.81M |
| Q32 Bio | 93.34M |